Certara has announced the acceleration of drug discovery and development through the integration of NVIDIA’s BioNeMo Agent Toolkit with its biosimulation software. This development will enable the unification of Certara’s products and datasets with AI-driven agents, providing specialized insights for life sciences. The move aligns with an industry trend where life sciences organizations are increasingly adopting AI agents to enhance research processes by combining computational tools with scientific expertise.
NVIDIA: NVIDIA develops AI platforms and computing technologies applicable across industries, including extensions into biological and medical domains. Its BioNeMo Agent Toolkit enables AI agents to process scientific data and simulations for targeted applications. The toolkit is central to a new integration with Certara’s biosimulation tools to accelerate life sciences workflows.
Certara: Certara provides biosimulation software, products, datasets, and scientific expertise tailored for the life sciences sector. The company is advancing its offerings by incorporating AI-driven capabilities to enhance drug discovery and development processes. This positions Certara to deliver more specialized insights through unified systems in pharmaceutical research.
BioNeMo Agent Toolkit: The BioNeMo Agent Toolkit is an AI solution from NVIDIA focused on generative biology and agent-based applications in drug-related research. It facilitates the creation of specialized agents that combine datasets, software, and domain expertise for enhanced analysis. This toolkit is being deployed to unify Certara’s resources and generate actionable insights in life sciences.
`json
{
“Product”: “Certara’s software integrates with NVIDIA’s BioNeMo Agent Toolkit to enhance biosimulation applications with AI capabilities.”,
“Industry Trend”: “The life sciences sector is increasingly adopting AI technologies to enhance the integration of computational tools and scientific expertise, aiming for greater efficiency in research and development.”
}
`